Abiopharma

🔍 Briger Peter L JR (Executive)

Company: Strategy Inc (MSTR)

Report Date: 2026-05-31

Detailed Transactions and Holdings:

• Holds 0 shares of Series A Perpetual Stretch Preferred Stock (Direct)
  Date: 2026-05-31 | Code: H | nature_of_ownership: 726 BF LLC | shares_owned_after: 220,000.00 | Footnotes: F1
• Acquired 1,221 shares of Director Stock Option (Right to buy) at $159.09 per share (Derivative)
  Date: 2026-05-31 | Code: A | Expires: 2036-05-31 | equity_swap_involved: false | shares_owned_after: 1,221.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Acquired 943 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-31 | Code: A | equity_swap_involved: false | shares_owned_after: 943.00 | transaction_form_type: 4 | Footnotes: F2, F4, F5, F5

Footnotes:

• F1: The reporting person is the manager of the limited liability company that owns the reported shares. The reporting person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
• F2: These grants were made pursuant to the Strategy Inc Equity Incentive Plan, as amended, which provides for the annual automatic grant of equity awards with an aggregate fair value of $300,000 (split evenly between restricted stock units ("RSUs") and options) to each non-employee director on May 31 of each year.
• F3: This option is scheduled to vest as to 1,221 shares on the first anniversary of the grant date.
• F4: Each RSU represents a contingent right to receive one share of class A common stock of Strategy Inc.
• F5: These RSUs are scheduled to vest as to 943 shares on the first anniversary of the grant date.